Skip to main content
Displaying 1 - 12 of 82
Display:
12
24
48
Metabolism, Alcohol & Toxicity
5
AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
5
AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
5
AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
5
AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
5
AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
6
Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
6
Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
6
Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
6
Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
6
Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
6
Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease - EASL SLD Summit 2025
View
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy